BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 20166080)

  • 21. Psychotropic analgesic nitrous oxide for alcoholic withdrawal states.
    Gillman MA; Lichtigfeld FJ; Young TN
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005190. PubMed ID: 17443576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.
    Gallimberti L; Canton G; Gentile N; Ferri M; Cibin M; Ferrara SD; Fadda F; Gessa GL
    Lancet; 1989 Sep; 2(8666):787-9. PubMed ID: 2571021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baclofen for alcohol withdrawal.
    Liu J; Wang LN
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008502. PubMed ID: 28822350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing treatments of alcoholism on craving and biochemical measures of alcohol consumptionst.
    Nava F; Premi S; Manzato E; Lucchini A
    J Psychoactive Drugs; 2006 Sep; 38(3):211-7. PubMed ID: 17165363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzodiazepines for alcohol withdrawal.
    Ntais C; Pakos E; Kyzas P; Ioannidis JP
    Cochrane Database Syst Rev; 2005 Jul; (3):CD005063. PubMed ID: 16034964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
    Pienaar ED; Young T; Holmes H
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003940. PubMed ID: 16856025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disulfiram for the treatment of cocaine dependence.
    Pani PP; Trogu E; Vacca R; Amato L; Vecchi S; Davoli M
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007024. PubMed ID: 20091613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review.
    Caputo F; Vignoli T; Maremmani I; Bernardi M; Zoli G
    Int J Environ Res Public Health; 2009 Jun; 6(6):1917-29. PubMed ID: 19578468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnesium for alcohol withdrawal.
    Sarai M; Tejani AM; Chan AH; Kuo IF; Li J
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008358. PubMed ID: 23740536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study.
    Caputo F; Addolorato G; Lorenzini F; Domenicali M; Greco G; del RE A; Gasbarrini G; Stefanini GF; Bernardi M
    Drug Alcohol Depend; 2003 May; 70(1):85-91. PubMed ID: 12681528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
    Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
    CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of sodium oxybate in alcohol-dependent patients with a very high drinking risk level.
    van den Brink W; Addolorato G; Aubin HJ; Benyamina A; Caputo F; Dematteis M; Gual A; Lesch OM; Mann K; Maremmani I; Nutt D; Paille F; Perney P; Rehm J; Reynaud M; Simon N; Söderpalm B; Sommer WH; Walter H; Spanagel R
    Addict Biol; 2018 Jul; 23(4):969-986. PubMed ID: 30043457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The gamma-hydroxybutyrate withdrawal syndrome.
    Tarabar AF; Nelson LS
    Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention.
    Skala K; Caputo F; Mirijello A; Vassallo G; Antonelli M; Ferrulli A; Walter H; Lesch O; Addolorato G
    Expert Opin Pharmacother; 2014 Feb; 15(2):245-57. PubMed ID: 24283802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: The Dutch GHB monitor project.
    Dijkstra BA; Kamal R; van Noorden MS; de Haan H; Loonen AJ; De Jong CA
    Drug Alcohol Depend; 2017 Jan; 170():164-173. PubMed ID: 27923198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baclofen for alcohol withdrawal.
    Liu J; Wang L
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008502. PubMed ID: 21249712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings.
    Denis C; Fatséas M; Lavie E; Auriacombe M
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005194. PubMed ID: 16856084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful Management of Gamma-hydroxybutyrate (GHB) Withdrawal Using Baclofen as a Standalone Therapy: A Case Report.
    Habibian S; Ahamad K; McLean M; Socias ME
    J Addict Med; 2019; 13(5):415-417. PubMed ID: 30907765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study.
    Elsing C; Stremmel W; Grenda U; Herrmann T
    Am J Drug Alcohol Abuse; 2009; 35(3):189-92. PubMed ID: 19462303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and therapy of alcohol withdrawal on intensive care units: systematic review of controlled trials.
    Ungur LA; Neuner B; John S; Wernecke K; Spies C
    Alcohol Clin Exp Res; 2013 Apr; 37(4):675-86. PubMed ID: 23550610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.